Literature DB >> 35943988

The strawberry-derived permeation enhancer pelargonidin enables oral protein delivery.

Nicholas G Lamson1, Katherine C Fein1, John P Gleeson1, Alexandra N Newby1, Sijie Xian1, Kyle Cochran1, Namit Chaudhary1, Jilian R Melamed1, Rebecca L Ball1, Kanika Suri1, Vishal Ahuja1,2, Anna Zhang1,2, Adrian Berger1,2, Dmytro Kolodieznyi3, Brigitte F Schmidt3, Gloria L Silva3, Kathryn A Whitehead1,2.   

Abstract

Although patients generally prefer oral drug delivery to injections, low permeability of the gastrointestinal tract makes this method impossible for most biomacromolecules. One potential solution is codelivery of macromolecules, including therapeutic proteins or nucleic acids, with intestinal permeation enhancers; however, enhancer use has been limited clinically by modest efficacy and toxicity concerns surrounding long-term administration. Here, we hypothesized that plant-based foods, which are well tolerated by the gastrointestinal tract, may contain compounds that enable oral macromolecular absorption without causing adverse effects. Upon testing more than 100 fruits, vegetables, and herbs, we identified strawberry and its red pigment, pelargonidin, as potent, well-tolerated enhancers of intestinal permeability. In mice, an oral capsule formulation comprising pelargonidin and a 1 U/kg dose of insulin reduced blood glucose levels for over 4 h, with bioactivity exceeding 100% relative to subcutaneous injection. Effects were reversible within 2 h and associated with actin and tight junction rearrangement. Furthermore, daily dosing of mice with pelargonidin for 1 mo resulted in no detectable side effects, including weight loss, tissue damage, or inflammatory responses. These data suggest that pelargonidin is an exceptionally effective enhancer of oral protein uptake that may be safe for routine pharmaceutical use.

Entities:  

Keywords:  oral drug delivery; permeation enhancers; protein therapeutics

Mesh:

Substances:

Year:  2022        PMID: 35943988      PMCID: PMC9388159          DOI: 10.1073/pnas.2207829119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  41 in total

Review 1.  Multifunctional strands in tight junctions.

Authors:  S Tsukita; M Furuse; M Itoh
Journal:  Nat Rev Mol Cell Biol       Date:  2001-04       Impact factor: 94.444

Review 2.  The strawberry: composition, nutritional quality, and impact on human health.

Authors:  Francesca Giampieri; Sara Tulipani; Josè M Alvarez-Suarez; Josè L Quiles; Bruno Mezzetti; Maurizio Battino
Journal:  Nutrition       Date:  2012-01       Impact factor: 4.008

Review 3.  Safety concerns over the use of intestinal permeation enhancers: A mini-review.

Authors:  Fiona McCartney; John P Gleeson; David J Brayden
Journal:  Tissue Barriers       Date:  2016-04-12

4.  Serum Lipopolysaccharide-Binding Protein is Associated with Chronic Inflammation and Metabolic Syndrome in Hemodialysis Patients.

Authors:  Paik Seong Lim; Yu-Kang Chang; Tsai-Kun Wu
Journal:  Blood Purif       Date:  2018-09-14       Impact factor: 2.614

5.  Ionic liquids for oral insulin delivery.

Authors:  Amrita Banerjee; Kelly Ibsen; Tyler Brown; Renwei Chen; Christian Agatemor; Samir Mitragotri
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

6.  Injection related anxiety in insulin-treated diabetes.

Authors:  A Zambanini; R B Newson; M Maisey; M D Feher
Journal:  Diabetes Res Clin Pract       Date:  1999-12       Impact factor: 5.602

7.  Medication adherence leads to lower health care use and costs despite increased drug spending.

Authors:  M Christopher Roebuck; Joshua N Liberman; Marin Gemmill-Toyama; Troyen A Brennan
Journal:  Health Aff (Millwood)       Date:  2011-01       Impact factor: 6.301

8.  Oral delivery of insulin using pH-responsive complexation gels.

Authors:  A M Lowman; M Morishita; M Kajita; T Nagai; N A Peppas
Journal:  J Pharm Sci       Date:  1999-09       Impact factor: 3.534

9.  Transient Permeation Enhancer® (TPE®) technology for oral delivery of octreotide: a technological evaluation.

Authors:  David J Brayden; Sam Maher
Journal:  Expert Opin Drug Deliv       Date:  2021-06-28       Impact factor: 6.648

10.  The role of I-FABP as a biomarker of intestinal barrier dysfunction driven by gut microbiota changes in obesity.

Authors:  Eva Lau; Cláudia Marques; Diogo Pestana; Mariana Santoalha; Davide Carvalho; Paula Freitas; Conceição Calhau
Journal:  Nutr Metab (Lond)       Date:  2016-04-30       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.